The Quinze-Vingts National Ophthalmology Hospital is France's national ophthalmology hospital located in Paris, in the 12th arrondissement. The hospital gave its name to the Quinze-Vingts quarter.

During the past decade, Centre de maladies rares CHNO des Quinze Vingts conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre de maladies rares CHNO des Quinze Vingts" are "Retinitis Pigmentosa" (2 trials), "Usher Syndrome Type 2" (2 trials), "Deaf Blind" (1 trials), "Eye Diseases" (1 trials) and "Eye Diseases, Hereditary" (1 trials). Many other conditions were trialed in "Centre de maladies rares CHNO des Quinze Vingts" in a lesser frequency.

Most popular intervention types in "Centre de maladies rares CHNO des Quinze Vingts" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "QR-421a" (1 trials), "RNA antisense oligonucleotide for intravitreal injection" (1 trials) and "Sham-procedure (dose cohort 1&2 only)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de maladies rares CHNO des Quinze Vingts" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre de maladies rares CHNO des Quinze Vingts". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre de maladies rares CHNO des Quinze Vingts, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre de maladies rares CHNO des Quinze Vingts, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".